Mankind Pharma Shares Soar 3% on Securing Rivotril Brand

Shares of Mankind Pharma Ltd soared 3% on 18 March after the company announced that it had acquired Roche’s Rivotril brand for the Indian market.

In a press release filed with the exchanges, the business stated that it has gained exclusive rights to produce, market, and distribute Rivotril in India, therefore strengthening its position in the chronic and central nervous system (CNS) therapeutics area.

Rivotril is a novel formulation of clonazepam that is frequently recommended for neurological and psychiatric problems.

Mankind Pharma stated that the acquisition adds a well-established brand with a solid clinical pedigree and specialist recall to its portfolio, complementing its current neuro/CNS products.

Atish Majumdar, Senior President, Sales & Marketing, Mankind Pharma Speciality Business, said, “This acquisition is aligned with our strategic focus on strengthening our presence in chronic therapies and speciality therapies.”

Citing strong opportunities through the platform, he said, “Leveraging our large field force and nationwide distribution network, we are well-positioned to build the brand and support physicians in delivering better outcomes for patients across India.”

Mankind Pharma further stated that the agreement opens prospects for future line extensions in the CNS segment, which will assist in addressing changing patient and physician demands.

Mankind Pharma presently works with over five lakh doctors and has a significant presence in both urban and semi-urban sectors, enabling broader penetration of its speciality portfolio.

The company’s net profit increased by 7.5% year on year to Rs 408.7 crore from Rs 380.2 crore in Q3FY25. Revenue increased by 11.5% YoY to Rs 3,567 crore from Rs 3,198 crore last year. EBITDA climbed 12.7% to Rs 919.6 crore from Rs 816.2 crore, with an EBITDA margin of 25.8%, compared to 25.5% in the same period of the previous year.

At 1:52 pm, the shares of Mankind Pharma were trading 2.45% higher at Rs 2,118.80 on NSE.

Unlock profitable opportunities every day! Tradz by EquityPandit provides actionable intraday trading signals for stocks and futures. Don’t miss out – download Tradz by EquityPandit and start winning now!

The post Mankind Pharma Shares Soar 3% on Securing Rivotril Brand appeared first on Equitypandit.